Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Francisco Gonzalez Carreras
Institutions:
GlaxoSmithKline (United Kingdom),
GlaxoSmithKline (United States),
GlaxoSmithKline Research & Development Limited (United Kingdom)
Observed institutions:
Queen Mary University of London,
GlaxoSmithKline (United Kingdom),
GlaxoSmithKline (United States),
GlaxoSmithKline Research & Development Limited (United Kingdom)
OpenAlex ID:
A5088646155
Clinical effectiveness and safety of time-lapse imaging systems for embryo incubation and selection in in-vitro fertilisation treatment (TILT): a multicentre, three-parallel-group, double-blind, randomised controlled trial
2024
·
Priya Bhide
, David Y L Chan
, et al.
·
The Lancet
·
61
PDF
The Effectiveness of Policies to combat Youth Unemployment
2015
·
Francisco Gonzalez Carreras
, Kirchner Sala Laura
, et al.
·
6
Longitudinal Assessment of Transfusion Intensity in Patients with JAK Inhibitor-Naive or -Experienced Myelofibrosis Treated with Momelotinib in the Phase 3 Simplify-1 and Momentum Trials
2023
·
Ruben A. Mesa
, Andrew C. Perkins
, et al.
·
Blood
·
3
MPN-088 Transfusion Intensity Over Time in Patients From the Phase 3 SIMPLIFY-1 and MOMENTUM Trials of Momelotinib
2024
·
Ruben Mesa
, Andrew Perkins
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Transfusion Intensity Over Time in Patients From the Phase 3 SIMPLIFY-1 and MOMENTUM Trials of Momelotinib
2024
·
Ruben Mesa
, Andrew Perkins
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Show more works
View as search
Works count:
5
Citation count:
70
H-index:
3
I10-index:
1
Year
Topic
Type
